Myosteatosis predicting risk of transition to severe COVID-19 infection

About 10-20% of patients with Coronavirus disease 2019 (COVID-19) infection progressed to severe illness within a week or so after initially diagnosed as mild infection. Identification of this subgroup of patients was crucial for early aggressive intervention to improve survival. The purpose of this study was to evaluate whether computer tomography (CT) - derived measurements of body composition such as myosteatosis indicating fat deposition inside the muscles could be used to predict the risk of transition to severe illness in patients with initial diagnosis of mild COVID-19 infection.

Source: Clinical Nutrition - June 6, 2021 Category: Nutrition Authors: Xiaoping Yi, Haipeng Liu, Liping Zhu, Dongcui Wang, Fangfang Xie, Linbo Shi, Ji Mei, Xiaolong Jiang, Qiuhua Zeng, Pingfeng Hu, Yihui Li, Peipei Pang, Jie Liu, Wanxiang Peng, Harrison X. Bai, Weihua Liao, Bihong T. Chen Tags: Covid-19 Source Type: research